Endurant Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Endurant Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,100	Closed	-$737K	–	106
2017 Q3	$737K	Sell	4,100 -12,300	-75%	-$1.71M	0.22%	74
2017 Q2	$1.7M	Buy	+16,400	New	+$1.34M	0.48%	52
2016 Q4	–	Sell	-9,800	Closed	-$547K	–	106
2016 Q3	$547K	Buy	+9,800	New	+$546K	0.2%	74

Endurant Capital Management's KITE Position: Q4 2017 in Review

Endurant Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,100 shares — an estimated $737K sold.

Endurant Capital Management first reported a position in KITE in Q3 2016 and held it in 3 quarters. The position peaked at $1.7M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Endurant Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Endurant Capital Management sold 4,100 Kite Pharma, Inc. shares in Q4 2017, an estimated $737K.
Endurant Capital Management first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 3 quarters.
Endurant Capital Management's Kite Pharma, Inc. position peaked at $1.7M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Endurant Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.